Table 1 Clinical characteristics of study patients
From: Tryptase as a marker of severity of aortic valve stenosis
Sex/age, years | MACE-patients | Non-MACE patients | |||
|---|---|---|---|---|---|
M/85 | F/58 | F/53 | F/72 | F/77 | |
Clinical history | |||||
Hypertension | Yes | Yes | Yes | Yes | Yes |
Hypercolesterolemia | No | Yes | No | Yes | Yes |
Currently smoking | Yes | No | No | No | No |
Diabetes mellitus | No | Yes | No | No | No |
Obesity | No | No | No | No | Yes |
COPD | Yes | No | No | No | No |
Left ventricle ejection fraction during index hospitalization | |||||
Ejection fraction (%) | 30 | 58 | 56 | 40 | 60 |
Mean transvalvular gradient (mmHg) | 70 | 75 | 70 | 65 | 65 |
Diagnostic findings | |||||
Tryptase, ng/ml | 10.9 | 11.7 | 9.32 | 5.69 | 5.58 |
CRP, mg/dl | 3.2 | 0.8 | 0.2 | 0.3 | 1.1 |
hsTnT, ng/l | 49.5 | 8.0 | 7.9 | 40 | 7.2 |
Serum triglycerides, mg/dl | 117 | 189 | 150 | 176 | 68 |
HDL cholesterol, mg/dl | 32 | 40 | 38 | 37 | 72 |
LDL cholesterol, mg/dl | 90 | 97 | 100 | 116 | 89 |
Plasma glucose, mg/dl | 119 | 181 | 104 | 87 | 114 |
Major cardiovascular events | Sudden death | STEACS | STEACS | None | None |